RB1 and small cell lung carcinoma: We found that wt RB1 mutation status was present in a minority (∼25%) of all SCLC patients in this cohort but was associated with significantly shorter overall (p = 0.002) and progression-free (p = 0.004) survival compared to patients with mutant RB1 (Figure 5G).